QUAD Investment Management: Funding, Team & Investors | Startup Intros

Loading organizations...

QUAD Investment Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jul 14, 2025	Illimis Therapeutics	$41.8M Series B	Yohan Kim	AJU IB Investment, A Ventures, Company K Partners, Daily Partners, GS Ventures, Hana Ventures, IMM Investment, Industrial Bank of Korea, Korea Development Bank, LB Investment, Maple Investment Partners, Schmidt, Shinhan Venture Investment, S&S Investment, TS Investment, Jiwoong Chun
May 24, 2024	HoneyNaps	$11.6M Series B	—	Hi Investment Partners, Industrial Bank of Korea
Nov 30, 2023	Novorex	$8.9M Series A	BNH Investment, Company K Partners, UTC Investment, Woori Venture Partners	Aon Investment, Hana Ventures, KB Investment, Technology Assurance Fund
Nov 13, 2023	NEUROPHET	$15.1M Series C	—	DB Financial Investment, Industrial Bank of Korea, KB Investment, Kolon Investment, Mirae Asset Securities, Profit Asset Management, Seoil E&M, Solidus Investment, Xoloninvest
Oct 31, 2023	Medipixel	$13.0M Series B	—	Company K Partners, Daily Partners, IMM Investment, Industrial Bank of Korea, Premier Partners, SBI Investment Korea
Sep 26, 2023	NeoCannBio	$7.4M Series B	Donghun Investment, Prologue Ventures, QUAD Investment Management	BM Ventures, HLB Investment, Medytox Investments
Aug 22, 2022	Avelos Therapeutics	$8.0M Series A	Mirae Asset Capital, Mirae Asset Venture Investment, QUAD Investment Management, SV Investment, Timefolio Asset Management, UTC Investment	—
Mar 16, 2022	Curiox Biosystems	$15.0M Series C	Lee Jong-hoon	KB Investment
May 26, 2021	Akili Interactive Labs	$160.0M Debt / Series D	Gabe Cahill	David Baszucki, Amgen Ventures, Canepa Advanced Healthcare Fund, Fearless Ventures, JAZZ Venture Partners, Ladera Venture Partners, Mirae Asset, M Ventures, New Leaf Venture Partners, Omidyar Technology Ventures, Polaris Partners, Shionogi & Co., Silicon Valley Bank, Temasek
Dec 1, 2020	Pear Therapeutics	$80.0M Series D	Elena Viboch	f7 Ventures, General Catalyst, 5AM Ventures, Arboretum Ventures, CrimsoNox Capital, EDBI, Forth Management, JAZZ Venture Partners, Novartis, Pilot House Ventures, Sarissa Capital, Shanda Group, Temasek
Jun 16, 2020	4D Molecular Therapeutics	$75.0M Series C	Viking Global Investors	Amzak Health, ArrowMark Partners, Berkeley Catalyst Fund, BVF Partners, Casdin Capital, Chiesi Ventures, Michael Boyle, Longevity Vision Fund, Mirae Asset, Octagon Capital, Perceptive Advisors
Oct 16, 2019	Curiox Biosystems	$15.0M Series B	—	DAYLI Investment, HB Investment, Aleum Lee, KB Investment, SV Investment
Aug 21, 2019	Oncorus	$79.5M Series B	Kevin Raidy, Ellen Hukkelhoven	Arkin Bio Ventures, Astellas Venture Management, Celgene, Deerfield Management, Mitchell Finer, Shinhan Venture Investment, Sphera Funds Management, Surveyor Capital, SV Investment, UTC Investment